Replies to post #131681 on Biotech Values

[DewDiligence]

Quiz: FDA approval of BSX’s Promus Element triggered a $40M charge against BSX’s 4Q11 earnings, an item that is buried in the PR in #msg-69267833.

Q: Why did FDA approval of a new product trigger a charge against earnings?